Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Dec 22;13(12):1233.
doi: 10.3390/antibiotics13121233.

Impact of Haemoadsorption Therapy on Short Term Mortality and Vasopressor Dependency in Severe Septic Shock with Acute Kidney Injury: A Retrospective Cohort Study

Affiliations

Impact of Haemoadsorption Therapy on Short Term Mortality and Vasopressor Dependency in Severe Septic Shock with Acute Kidney Injury: A Retrospective Cohort Study

Danny Epstein et al. Antibiotics (Basel). .

Abstract

Background/Objectives: Sepsis, a life-threatening organ dysfunction caused by a dysregulated host response to infection, remains a major challenge in ICUs. This study evaluated whether combining haemoadsorption therapy with continuous renal replacement therapy (CRRT) reduces ICU and short-term mortality in patients with severe septic shock and acute kidney injury (AKI) requiring CRRT. Methods: A single-centre retrospective cohort study was conducted at Rambam Health Care Campus, Haifa, Israel, from January 2018 to February 2024. Data were collected from ICU patients with severe septic shock and AKI requiring CRRT. Patients were divided into two groups: those receiving haemoadsorption therapy with CRRT and those receiving CRRT alone. Primary and secondary endpoints included ICU, 30 and 60-day mortality, vasopressor dependency index (VDI), and lactate levels. Results: Out of 545 patients with septic shock, 133 developed AKI requiring CRRT, and 76 met the inclusion criteria. The haemoadsorption group (n = 47) showed significant reductions in blood lactate levels and VDI after 24 h compared to the CRRT alone group (n = 29). ICU mortality was significantly lower in the haemoadsorption group (34.0% vs. 65.5%, p = 0.008), as was 30 and 60-day mortality (34.0% vs. 62.1%, p = 0.02, and 48.9% vs. 75.9%, p = 0.002). Multivariate analysis confirmed haemoadsorption therapy as independently associated with lower ICU and 30-day but not 60-day mortality. Conclusions: Haemoadsorption therapy combined with CRRT in patients with severe septic shock and AKI requiring CRRT is associated with improved lactate clearance, reduced vasopressor requirements, and lower ICU and 30-day mortality. Further high-quality randomized controlled trials are needed to confirm these findings.

Keywords: Cytosorb; Oxiris; acute kidney injury; continuous renal replacement therapy; cytokine removal; haemoadsorption; septic shock.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Study flow chart. ICU, intensive care unit; CRRT, continuous renal replacement therapy.
Figure 2
Figure 2
Kaplan–Meier survival curves comparing continuous renal replacement therapy with and without a cytokine-absorbing filter. CRRT, continuous renal replacement therapy.

Similar articles

Cited by

References

    1. La Via L., Sangiorgio G., Stefani S., Marino A., Nunnari G., Cocuzza S., La Mantia I., Cacopardo B., Stracquadanio S., Spampinato S., et al. The Global Burden of Sepsis and Septic Shock. Epidemiologia. 2024;5:456–478. doi: 10.3390/epidemiologia5030032. - DOI - PMC - PubMed
    1. Singer M., Deutschman C.S., Seymour C.W., Shankar-Hari M., Annane D., Bauer M., Bellomo R., Bernard G.R., Chiche J.-D., Coopersmith C.M., et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3) JAMA. 2016;315:801. doi: 10.1001/jama.2016.0287. - DOI - PMC - PubMed
    1. Bonavia A., Groff A., Karamchandani K., Singbartl K. Clinical Utility of Extracorporeal Cytokine Hemoadsorption Therapy: A Literature Review. Blood Purif. 2018;46:337–349. doi: 10.1159/000492379. - DOI - PubMed
    1. Saldaña-Gastulo J.J.C., Llamas-Barbarán M.D.R., Coronel-Chucos L.G., Hurtado-Roca Y. Cytokine Hemoadsorption with CytoSorb® in Patients with Sepsis: A Systematic Review and Meta-Analysis. Crit. Care Sci. 2023;35:217–225. doi: 10.5935/2965-2774.20230289-en. - DOI - PMC - PubMed
    1. Siew L.Y., Lee Z.-Y., Yunos N.M., Atan R., Cove M.E., Lumlertgul N., Srisawat N., Hasan M.S. Outcomes of Extracorporeal Blood Purification with OXiris® Membrane in Critically Ill Patients: A Systematic Review and Meta-Analysis. J. Crit. Care. 2024;83:154844. doi: 10.1016/j.jcrc.2024.154844. - DOI - PubMed

LinkOut - more resources